๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates

โœ Scribed by Jane L. Wang; Karl Aston; David Limburg; Cindy Ludwig; Ann E. Hallinan; Francis Koszyk; Bruce Hamper; David Brown; Matthew Graneto; John Talley; Timothy Maziasz; Jaime Masferrer; Jeffery Carter

Book ID
104004664
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
742 KB
Volume
20
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The novel benzopyran class of selective
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life
โœ Jane L. Wang; David Limburg; Matthew J. Graneto; John Springer; Joseph Rogier Br ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 811 KB

In this Letter, we provide the structure-activity relationships, optimization of design, testing criteria, and human half-life data for a series of selective COX-2 inhibitors. During the course of our structure-based drug design efforts, we discovered two distinct binding modes within the COX-2 acti

Correction to Discovery of a Novel Class
Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazin-6-yl)-1 H -pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer
โœ Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dubรฉ, Michelle; Pairish, M ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› American Chemical Society ๐ŸŒ English โš– 124 KB